Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FABP5 | Q01469 | 3/20 | 0.46 |
| ▸ | FABP7 | O15540 | 2/20 | 0.46 |
| ▸ | FFAR2 | O15552 | 5/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.39 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.37 |
| ▸ | MAOA | P21397 | 1/20 | 0.37 |
| ▸ | MAOB | P27338 | 1/20 | 0.37 |
| ▸ | CASP3 | P42574 | 1/20 | 0.36 |
| ▸ | HCRTR2 | O43614 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31159434 | 0.91 | FABP5 (0.51) | FABP5FABP7FFAR2KMT2A | |
| SCHEMBL799703 | 0.91 | FABP5 (0.51) | FABP5FABP7FFAR2KMT2A | |
| SCHEMBL3366299 | 0.91 | FABP5 (0.51) | FABP5FABP7FFAR2KMT2A | |
| Fluoride SCHEMBL7821537 | 0.89 | FABP5 (0.50) | FABP5FABP7FFAR2KMT2A | |
| SCHEMBL31369486 | 0.85 | ACE (0.47) | FABP5FABP7FFAR2MAOAMAOB | |
| SCHEMBL31370144 | 0.84 | FABP5 (0.49) | FABP5FABP7FFAR2KMT2AEPHX2 | |
| SCHEMBL31369417 | 0.83 | FFAR2 (0.44) | FABP5FABP7FFAR2EPHX2 | |
| SCHEMBL31369524 | 0.81 | FFAR2 (0.56) | FABP5FABP7FFAR2 | |
| SCHEMBL31370160 | 0.79 | FFAR2 (0.41) | FABP5FABP7FFAR2 | |
| SCHEMBL3727517 | 0.78 | XIAP (0.46) | KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190688-A1 | Tetrapeptide analogs | IDUN PHARMACEUTICALS, INC. | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100190688-A1 | Tetrapeptide analogs | TP53, PCNA, HRAS | FABP5 2556/4885FABP7 4167/4885FFAR2 4350/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.